Fosamax - Are chemotherapy patients at risk?

Fosamax is commonly combined with intravenous chemotherapy treatments given to cancer patients to prevent Osteoporosis.

Patients may undergo these treatments, sometimes weekly or bi-weekly, for up to one year or longer.

Fosamax, particularly when dispensed intravenously, has been shown to cause a general hardening of the bones (bones become brittle) and has also been linked to a medical condition that causes the jaw bone to rot (Osteonecrosis of the Jaw).

If you or a loved one have been diagnosed with ONJ (Dead Jaw), Weitz and Luxenberg may be able to get you compensation for your pain and suffering.

Click To Talk To Us Online

Myofascial Pain Syndrome

Fosamax & Myofascial Pain Syndrome - Learn about the connection
Fosamax - Myofascial Pain Syndrome: malfunctioning of the fascial system

Oral Fosamax

Oral Fosamax - Learn about Oral Administering of Fosamax
Are you at risk if you take Fosamax Orally? FREE Case Evaluation

Learn More

Learn more about Fosamax - Are you at risk? Find out here
Learn more about Fosamax - Dangerous health risks linked with Fosamax

Name

Phone

strictly confidential

Your Question

First Name
Last Name
Home Phone
Work Phone
Best Time to Call
City and State
Email
When did you start taking Fosamax?
When did you stop taking Fosamax?
How were you taking Fosamax?
What dosage were you taking?
Did you develop Osteonecrosis of the Jaw (Dead Jaw)?	Yes
How long were you taking Fosamax before you developed Osteonecrosis?
Did you have dental work done in the month before the Osteonecrosis developed?	Yes No
What type of treatment did you have?
Please describe any ongoing complications:
Additional Comments: